Literature DB >> 16528383

Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis.

Z Szondy, P G Mastroberardino, J Váradi, M G Farrace, N Nagy, I Bak, I Viti, M R Wieckowski, G Melino, R Rizzuto, A Tósaki, L Fesus, M Piacentini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16528383     DOI： 10.1038/sj.cdd.4401889

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  26 in total

1.  Transglutaminase 2 protects against ischemic stroke.

Authors:  A J Filiano; J Tucholski; P J Dolan; G Colak; G V W Johnson
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

Review 2.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

Review 3.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

Review 4.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

5.  Transglutaminase 2 inhibits apoptosis induced by calcium- overload through down-regulation of Bax.

Authors:  Sung-Yup Cho; Jin-Haeng Lee; Han-Dong Bae; Eui Man Jeong; Gi-Yong Jang; Chai-Wan Kim; Dong-Myung Shin; Ju-Hong Jeon; In-Gyu Kim
Journal:  Exp Mol Med       Date:  2010-09-30       Impact factor: 8.718

Review 6.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

7.  Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.

Authors:  Anthony J Filiano; Craig D C Bailey; Janusz Tucholski; Soner Gundemir; Gail V W Johnson
Journal:  FASEB J       Date:  2008-03-28       Impact factor: 5.191

Review 8.  Transglutaminase 2 inhibitors and their therapeutic role in disease states.

Authors:  Matthew Siegel; Chaitan Khosla
Journal:  Pharmacol Ther       Date:  2007-05-13       Impact factor: 12.310

9.  Modulation of transglutaminase 2 activity in H9c2 cells by PKC and PKA signalling: a role for transglutaminase 2 in cytoprotection.

Authors:  Ibtesam Almami; John M Dickenson; Alan J Hargreaves; Philip L R Bonner
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

10.  Lack of transglutaminase 2 diminished T-cell responses in mice.

Authors:  Jin-Hee Kim; Jun Man Hong; Eui Man Jeong; Wang Jae Lee; Hang-Rae Kim; Jae Seung Kang; In-Gyu Kim; Young-Il Hwang
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.